Boardroom Alpha
Boardroom Alpha
WABC · Current Report (Form 8-K) · Filed April 27, 2026

Westamerica Bancorporation — Current Report (Form 8-K)

Form
8-K
Filed
April 27, 2026
Period
Apr 24, 2026
Ticker
WABC
Accession
0001171843-26-002737
Boardroom Alpha · Filing insights

Shareholders elected all eight director nominees for one-year terms, approved advisory executive compensation, and ratified Crowe LLP as independent auditors.

About Westamerica Bancorporation
Market cap
$1.3B
1Y TSR
+25.3%
3Y TSR
+12.4%
Board grade
C-
Sector
Financial Services
CEO
David L Payne
Last annual meeting: Apr 23, 2026 · View full Westamerica Bancorporation profile →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): April 24, 2026

 

 

Westamerica Bancorporation

(Exact name of registrant as specified in its charter)

 

 

 

California   001-09383   94-2156203

(State or other jurisdiction

of incorporation)

 

(Commission

File No.)

 

(IRS Employer

Identification Number)

   

1108 Fifth Avenue

San Rafael, California

  94901
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (707) 863-6000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Section 5 – Corporate Governance and Management

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

Proxies for the Annual Meeting of shareholders held on April 23, 2026, were solicited pursuant regulation 14A of the Securities Exchange Act of 1934. The Report of Inspector of election indicates that 20,862,774 shares of the Common Stock of the Company, out of 24,189,404 shares outstanding on the March 4, 2026 record date, were present, in person or by proxy, at the meeting. The following matters were submitted to a vote of the shareholders:

 

Proposal 1. Election of Directors

 

The shareholders elected all of the Board of Director nominees for a term of one year, as follows:

 

Nominee For Against Abstain Non-Votes
 Alisa Belew 18,490,079 255,468 43,008    2,074,219
 Martin Camsey 18,488,488 257,069 42,998    2,074,219
 Melanie M. Chiesa 18,412,425 331,069 45,061    2,074,219
 Michele Hassid 18,298,021 443,477 47,057    2,074,219
 David L. Payne 18,505,822 249,587 33,146    2,074,219
 Edward B. Sylvester 18,085,396 666,724 36,435    2,074,219
 Carter Welch 18,582,179 163,417 42,959    2,074,219
 Inez Wondeh 18,464,962 280,293 43,300    2,074,219

 

Proposal 2. Approve a Non-Binding Advisory Vote on Executive Compensation

 

The shareholders approved, on an advisory non-binding basis, the compensation of Westamerica Bancorporation’s named executive officers, by the following vote:

 

For Against Abstain Non-Votes
18,355,387 379,196 53,972 2,074,219

 

Proposal 3. Ratify Selection of Crowe LLP as Company’s Independent Auditors for Fiscal Year 2026

 

The shareholders ratified the appointment of Crowe LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, by the following vote:

 

For Against Abstain Non-Votes
20,502,455 239,365 120,954 -0-

 

 

 

 2 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

             
        WESTAMERICA BANCORPORATION
                   (Registrant)
       
Date: April 27, 2026       By:   /s/ Anela Jonas
            Anela Jonas
            Senior Vice President and Chief Financial Officer

 

 

 

 

 

3

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Westamerica Bancorporation (WABC)

Reference

Frequently asked questions

When did Westamerica Bancorporation file this 8-K?
Westamerica Bancorporation (WABC) filed this Current Report (Form 8-K) with the SEC on April 27, 2026. The accession number assigned by EDGAR is 0001171843-26-002737.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders elected all eight director nominees for one-year terms, approved advisory executive compensation, and ratified Crowe LLP as independent auditors. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Westamerica Bancorporation's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Westamerica Bancorporation has filed under CIK 311094, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer